Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 52

Cited In for PubMed (Select 17239714)

1.

Ventricular repolarization markers for predicting malignant arrhythmias in clinical practice.

Castro-Torres Y, Carmona-Puerta R, Katholi RE.

World J Clin Cases. 2015 Aug 16;3(8):705-20. doi: 10.12998/wjcc.v3.i8.705. Review.

2.

Never Out of the Woods: Onset of Events in Long QT Syndrome Late in Life Provoked by Atrial Arrhythmias.

Ng J, Barbhaiya C, Reichlin T, Nagashima K, John R.

Indian Pacing Electrophysiol J. 2014 Oct 6;14(5):263-7. eCollection 2014 Sep.

3.

How do sex hormones modify arrhythmogenesis in long QT syndrome? Sex hormone effects on arrhythmogenic substrate and triggered activity.

Odening KE, Koren G.

Heart Rhythm. 2014 Nov;11(11):2107-15. doi: 10.1016/j.hrthm.2014.06.023. Epub 2014 Jun 19. Review.

4.

Oral contraceptive use and the risk of cardiac events in patients with long QT syndrome.

Abu-Zeitone A, Peterson DR, Polonsky B, McNitt S, Moss AJ.

Heart Rhythm. 2014 Jul;11(7):1170-5. doi: 10.1016/j.hrthm.2014.04.016. Epub 2014 Apr 13.

5.

Multiscale complexity analysis of the cardiac control identifies asymptomatic and symptomatic patients in long QT syndrome type 1.

Bari V, Valencia JF, Vallverdú M, Girardengo G, Marchi A, Bassani T, Caminal P, Cerutti S, George AL Jr, Brink PA, Crotti L, Schwartz PJ, Porta A.

PLoS One. 2014 Apr 4;9(4):e93808. doi: 10.1371/journal.pone.0093808. eCollection 2014.

6.

Genetic Test for the Channelopaties: Useful or Less Than Useful for Patients? (Part II).

Romano R, Parisi V, Pastore F, Riccio A, Petraglia L, Allocca E, Leosco D.

Transl Med UniSa. 2013 May 6;6:35-40. eCollection 2013.

7.

Long QT syndrome: a Korean single center study.

Lee YS, Kwon BS, Kim GB, Oh SI, Bae EJ, Park SS, Noh CI.

J Korean Med Sci. 2013 Oct;28(10):1454-60. doi: 10.3346/jkms.2013.28.10.1454. Epub 2013 Sep 25.

8.

Genotype- and phenotype-guided management of congenital long QT syndrome.

Giudicessi JR, Ackerman MJ.

Curr Probl Cardiol. 2013 Oct;38(10):417-55. doi: 10.1016/j.cpcardiol.2013.08.001. Review.

9.

Acquired Long QT Syndrome Manifesting with Torsades de Pointes in a Patient with Panhypopituitarism due to Radiotherapy.

Kang DG, Kim SE, Park MS, Kim EJ, Lee JH, Park DG, Han KR, Oh DJ.

Korean Circ J. 2013 May;43(5):340-2. doi: 10.4070/kcj.2013.43.5.340. Epub 2013 May 31.

10.

Induced pluripotent stem cells used to reveal drug actions in a long QT syndrome family with complex genetics.

Terrenoire C, Wang K, Tung KW, Chung WK, Pass RH, Lu JT, Jean JC, Omari A, Sampson KJ, Kotton DN, Keller G, Kass RS.

J Gen Physiol. 2013 Jan;141(1):61-72. doi: 10.1085/jgp.201210899.

11.

Clinical and genetic determinants of torsade de pointes risk.

Sauer AJ, Newton-Cheh C.

Circulation. 2012 Apr 3;125(13):1684-94. doi: 10.1161/CIRCULATIONAHA.111.080887. Review. No abstract available.

12.

Mutations in cytoplasmic loops of the KCNQ1 channel and the risk of life-threatening events: implications for mutation-specific response to β-blocker therapy in type 1 long-QT syndrome.

Barsheshet A, Goldenberg I, O-Uchi J, Moss AJ, Jons C, Shimizu W, Wilde AA, McNitt S, Peterson DR, Zareba W, Robinson JL, Ackerman MJ, Cypress M, Gray DA, Hofman N, Kanters JK, Kaufman ES, Platonov PG, Qi M, Towbin JA, Vincent GM, Lopes CM.

Circulation. 2012 Apr 24;125(16):1988-96. doi: 10.1161/CIRCULATIONAHA.111.048041. Epub 2012 Mar 28.

13.

Age-and sex-dependent mRNA expression of KCNQ1 and HERG in patients with long QT syndrome type 1 and 2.

Moric-Janiszewska E, Głogowska-Ligus J, Paul-Samojedny M, Węglarz L, Markiewicz-Łoskot G, Szydłowski L.

Arch Med Sci. 2011 Dec 31;7(6):941-7. doi: 10.5114/aoms.2011.26604. Epub 2011 Dec 30.

14.

Clinical cardiac safety profile of nilotinib.

Kim TD, le Coutre P, Schwarz M, Grille P, Levitin M, Fateh-Moghadam S, Giles FJ, Dörken B, Haverkamp W, Köhncke C.

Haematologica. 2012 Jun;97(6):883-9. doi: 10.3324/haematol.2011.058776. Epub 2012 Jan 22.

15.

Estradiol promotes sudden cardiac death in transgenic long QT type 2 rabbits while progesterone is protective.

Odening KE, Choi BR, Liu GX, Hartmann K, Ziv O, Chaves L, Schofield L, Centracchio J, Zehender M, Peng X, Brunner M, Koren G.

Heart Rhythm. 2012 May;9(5):823-32. doi: 10.1016/j.hrthm.2012.01.009. Epub 2012 Jan 11.

16.

QT-interval duration and mortality rate: results from the Third National Health and Nutrition Examination Survey.

Zhang Y, Post WS, Dalal D, Blasco-Colmenares E, Tomaselli GF, Guallar E.

Arch Intern Med. 2011 Oct 24;171(19):1727-33. doi: 10.1001/archinternmed.2011.433.

17.

Anger, emotion, and arrhythmias: from brain to heart.

Taggart P, Boyett MR, Logantha S, Lambiase PD.

Front Physiol. 2011 Oct 19;2:67. doi: 10.3389/fphys.2011.00067. eCollection 2011.

18.

A null mutation of the neuronal sodium channel NaV1.6 disrupts action potential propagation and excitation-contraction coupling in the mouse heart.

Noujaim SF, Kaur K, Milstein M, Jones JM, Furspan P, Jiang D, Auerbach DS, Herron T, Meisler MH, Jalife J.

FASEB J. 2012 Jan;26(1):63-72. doi: 10.1096/fj.10-179770. Epub 2011 Sep 24.

19.

Electrocardiographic QT interval and mortality: a meta-analysis.

Zhang Y, Post WS, Blasco-Colmenares E, Dalal D, Tomaselli GF, Guallar E.

Epidemiology. 2011 Sep;22(5):660-70. doi: 10.1097/EDE.0b013e318225768b.

20.

Common genetic variants, QT interval, and sudden cardiac death in a Finnish population-based study.

Noseworthy PA, Havulinna AS, Porthan K, Lahtinen AM, Jula A, Karhunen PJ, Perola M, Oikarinen L, Kontula KK, Salomaa V, Newton-Cheh C.

Circ Cardiovasc Genet. 2011 Jun;4(3):305-11. doi: 10.1161/CIRCGENETICS.110.959049. Epub 2011 Apr 21.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk